Paul B Manning
CIK 1494695 · last filed 2026-10-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VRCA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
CHARLOTTESVILLE, VA 22902
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CADL | Director | 2,984,752 | $9.49 | $28.33M | $23.91M | 14 | 2026-10-02 |
| LQDA | Director | 911,139 | $47.87 | $43.62M | -$24.24M | 16 | 2026-06-18 |
| VRCA | Director | 7,306,561 | $3.59 | $26.23M | $48.04M | 17 | 2025-11-25 |
| TSHA | Director | 1,355,333 | $4.37 | $5.92M | $25.15M | 13 | 2025-06-03 |
| ABOS | 10%+ Owner | 3,040,193 | $0.24 | $720.5K | $5.00M | 1 | 2021-07-08 |
| Dova Pharmaceuticals Inc. (DOVA) Delisted | Director | 0 | — | — | $7.34M | 8 | 2019-11-12 |
| AveXis, Inc. (AVXS) Delisted | Director | 0 | — | — | -$10.00M | 6 | 2018-05-15 |
Recent Filings · Page 2 of 8
78 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-02 | LQDA | Sell (S) | −670,837 | -$18.96M | EDGAR |
| 2025-08-29 | LQDA | Notice (144) | −947,328 | -$26.15M | EDGAR |
| 2025-08-28 | LQDA | Notice (144) | −154,337 | -$4.31M | EDGAR |
| 2025-06-26 | CADL | Grant (A) | +1,070,663 | $5.00M | EDGAR |
| 2025-06-20 | LQDA | Grant (A) | +18,396 | $0 | EDGAR |
| 2025-06-18 | CADL | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | TSHA | Buy (P) | +750,000 | $2.06M | EDGAR |
| 2024-12-18 | CADL | Buy (P) | +1,250,000 | $7.50M | EDGAR |
| 2024-11-26 | VRCA | Mixed | +22,471,348 | $0 | EDGAR |
| 2024-09-23 | VRCA | Gift (G) | −891,870 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.